CUSIP: 38341P102 | NYSE | Healthcare · Biotechnology | Micro Cap | 512 institutional holders
5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.
| Holder | Shares | % of Class | Change | Event Date | vs 13F |
|---|---|---|---|---|---|
| 13D/AD. E. Shaw & Co., L.L.C. with D. E. Shaw Valence Portfolios, L.L.C. | 29,128,194 | 6.0% | −5,220,764 | Aug 20, 2026 | No 13F filer matched |
| 13GOpaleye Management Inc. with Opaleye, L.P. | 24,942,565 | 5.1% | New 5%+ stake | Jul 22, 2026 | No 13F filer matched |
| 13D/AGrowth Equity Opportunities 18 VGE, LLC | 4,065,134 | 1.7% | Newly reported | Feb 23, 2026 | No 13F filer matched |
| Style | Turnover | Location | Filed | ||||
|---|---|---|---|---|---|---|---|
| 98 | $14 | 0.0% | Growth | Low | Tampa, FL | 2026-10-16 |